US › Healthcare

MDxHealth SA ADR (MDXH)

US · Healthcare · Diagnostics & Research

$0.44-2.86%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$54.7M

Revenue YoY

+125.0%

Net profit

$-18.8M

Profit YoY

-103.9%

EPS

$-0.17

EPS estimate

$-0.15

Net margin

-34.3%

EPS came in at -0.17 against a street estimate of -0.15 — a miss of 13.3%.

Key statistics

Market cap

$21.5M

Forward P/E

27.7

P/B

23.64

Book value

$-0.39

EPS (TTM)

$-0.65

52-week high

$5.33

52-week low

$0.40

50-day MA

$0.53

200-day MA

$2.56

Beta

-503,341.44

Analyst view

Analysts rate MDxHealth SA ADR a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $2.80.

Shareholding

Insiders

11.13%

Institutions

38.04%

Largest institutional holders

Fund	Stake
Rhumbline Advisers	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for MDxHealth SA ADR — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.